ClinicalTrials.Veeva

Menu

Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy

University of Kansas logo

University of Kansas

Status

Withdrawn

Conditions

Urinary Bladder Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05335707
IIT-2021-GerioncBladder

Details and patient eligibility

About

This single arm pilot study will evaluate the feasibility and acceptability for perioperative Comprehensive Geriatric Assessment (CGA) and CGA-directed supportive and restorative care for patients with muscle-invasive bladder cancer who are planned to undergo preoperative chemotherapy.

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability of participant OR Legally Authorized Representative (LAR) to understand this study, and participant or LAR willingness to sign a written informed consent
  • Males and females age ≥ 65 years
  • Diagnosis/disease status
  • Histologically proven muscle-invasive bladder cancer (MIBC) without metastatic disease.
  • Patients planning to undergo neoadjuvant chemotherapy and radical cystectomy for MIBC.
  • Treatment with investigational systemic therapy is permitted if participants will be receiving chemotherapy as part of their treatment plan

Exclusion criteria

  • Diagnosed with a psychiatric illness or is in a social situation that would limit compliance with study requirements
  • Any other known invasive malignancy within previous 2 years with the following EXCEPT: low grade prostate cancer on active surveillance, chronic lymphocytic leukemia CLL on surveillance / observation, non-melanoma skin cancers

Trial contacts and locations

0

Loading...

Central trial contact

KUCC Navigation

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems